Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 6Recruiting 3Enrolling by invitation 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 543Neoplasms 383Carcinoma, Non-Small-Cell Lung 320Colorectal Neoplasms 294Lung Neoplasms 239Prostatic Neoplasms 221Carcinoma, Hepatocellular 213Stomach Neoplasms 156Pancreatic Neoplasms 153Leukemia, Myeloid, Acute 140Uterine Cervical Neoplasms 131Multiple Myeloma 130Recurrence 118Rectal Neoplasms 113Ovarian Neoplasms 108Neoplasm Metastasis 104Squamous Cell Carcinoma of Head and Neck 97Head and Neck Neoplasms 88Triple Negative Breast Neoplasms 86Esophageal Neoplasms 85Endometrial Neoplasms 81Glioblastoma 80Small Cell Lung Carcinoma 79Colonic Neoplasms 79Brain Neoplasms 76Melanoma 72Hematologic Neoplasms 66Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Glioma 62Disease 60

Interventions

telitacicept 1Population Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neuromuscular Diseases × Clear all
NCT06827587 2025-02-14

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase NA Not yet recruiting
60 enrolled

Autoimmune Diseases, Myasthenia Gravis, Neuromuscular Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡